SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $882,000 | -23.4% | 6,289 | 0.0% | 0.02% | -20.7% |
| Q2 2019 | $1,151,000 | +15.2% | 6,289 | +0.1% | 0.03% | +16.0% |
| Q1 2019 | $999,000 | -11.6% | 6,283 | -46.7% | 0.02% | -13.8% |
| Q4 2018 | $1,130,000 | -34.9% | 11,797 | -4.0% | 0.03% | -31.0% |
| Q3 2018 | $1,736,000 | -17.5% | 12,293 | -8.5% | 0.04% | -16.0% |
| Q2 2018 | $2,103,000 | -34.7% | 13,433 | -32.8% | 0.05% | -39.0% |
| Q1 2018 | $3,219,000 | -25.8% | 19,988 | -24.1% | 0.08% | -27.4% |
| Q4 2017 | $4,340,000 | +68.9% | 26,347 | -36.1% | 0.11% | +71.2% |
| Q3 2017 | $2,570,000 | -21.8% | 41,250 | 0.0% | 0.07% | -29.8% |
| Q2 2017 | $3,285,000 | – | 41,250 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |